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From 15 May to 15 December 1994, 2943 patients suspected of having contact dermatitis (1955 
women, 988 men) were patch tested with methyldibromoglutaronitrile 0.3%, 0.1% and 0.05% pet. 
119 patients (4.0%; women 4.1%), men 3.8%) proved to be allergic. 71% of the reactions were 
considered to be relevant. In 2/3 of the patients, causative products were cosmetics, in 1/3 moistened 
toilet tissues. Testing with methyldibromoglutaronitrile at lower concentrations (0.05% and 0.1%) 
and with commercial allergens (Euxyl® K 400 and methyldibromoglutaronitrile, both containing 
methyldibromoglutaronitrile 0.1 %>), resulted in a number of false-negative reactions. All preserv­
atives in the European standard series had lower scores than the 4% positive reactions to methyldi­
bromoglutaronitrile (formaldehyde 2.0%), MCI/MI (Kathon® CG) 3.2%, parabens 1.0%o, quat- 
ernium-15 1.3%). It is concluded that methyldibromoglutaronitrile (present in the commercial pre­
servative Euxyl® K 400) is an important contact allergen in the Netherlands in cosmetics and 
moistened toilet tissues. It should be added to cosmetics series and to proctological series. The 
optimal test concentration is unknow, but may be 0.3% pet. The concentration o f 0.1% methyldi­
bromoglutaronitrile in the currently available commercial allergens appears to be too low, resulting 
in a number of false-negative reactions.
Key words: methyldibromoglutaronitrile; Euxyl® K 400; preservatives; 1,2-dibromo-2,4-dicyanobu- 
tane; contact allergy; cosmetics; moistened toilet tissues; patch testing technique. © Munksgaard,
1996.
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In 1991, the Dutch Contact Dermatitis group 
found a 0.5% frequency of positive reactions to 
methyldibromoglutaronitrile (1,2-dibromo-2,4-di- 
cyanobutane) in patients suspected of having con­
tact dermatitis (1). At that time, it was decided to
Materials and Methods
May to 15 December 1994, methyldibro- 
anitrile was added to the European stan­
ds and tested in all oatients susoected of
ment
repeat the study after some years, to monitor its having contact dermatitis by the participating 
possible emergence as an important contact aller- members of the Dutch Contact Dermatitis Work- 
gen, as methyldibromoglutaronitrile was rapidly group. The allergens were prepared by the Re­
gaining popularity in the cosmetics industry as a gional Inspectorate for Health Protection, Depart-
of Cosmetics, Enschede (JWW). Concen- 
ons were 0.05%, 0.1%) and 0.3% w/w pet.; soy 
lin was added to obtain homogeneous disper- 
>. Therefore, soy lecithin 5% was also tested in 
atients. In some hospitals, Euxyl® K 400 0.5% 
(Chemotechnique, containing 0.1% methyldi-
substitute for methyl (chloro) isothiazolinone (Ka­
thon® CG). The latter preservative was, in many 
European countries, one of the most common 
allergens (2).
The repeat study, performed in 1994, aimed at 
determining the current frequency of contact al­
lergy to methyldibromoglutaronitrile, identifying bromoglutaronitrile) and/or 
the products that cause dermatitis and exploring
the influence of test concentrations on the patch 
test results.
nitrile 0.1% pet. (Trolab) were also tested.
The following data were recorded for all patients
tested
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Table /. Results and evaluation of patch testing with melhyldibromoglutaronitrile
RangevU )
No. of patients tested: 2943 (range 159-447)
number of women 1955 (66%) (range 62%.--72%)
number of men 988 (34%.) (range 28%~38%)
Age range (years) 8-86
Average age (years) 38 (range 29-43 year)
Total number of positive reactions: 119
Total number of positive reactions in women: 81
Total number of positive reactions in men: 38
% of patients positive: 4.0% (range 1.4% 12%)b)
% of women positive: 4.1% (range 1.8% 12.5%)
%> of men positive: 3.8% (range 0% 11.1%)
Number of relevant reactions: 84 (71%) (range 40%-100%)
Relevant products: cosmetics: 60
moistened toilet tissues: 30
Reactions to different concentrations of methyldibromoglutaronitrile: 0.3% : 115 
0.1%. : 103 
0.05%: 85
% of positive reactions with commercial Euxyl® K 400 0.5%: 69%
% of positive reactions with commercial methyldibromoglutaronitrile 0.1% pet.:
Reactions to methyldibromoglutaronitrile compared with other preservatives in the 
European standard series:
7 3%
methyldibromoglutaronitrile 4.0%. (range 1.4%- 12%.)
formaldehyde 2.0% (range 0.0%-3.8%.)
Kathon® CG (MI/MCI) 3.2% (range 0.6%-7.2%.)
parabens 1.0% (range 0.0%-3.8%)
quaternium-15 1.3% (range 0.4%.- 2.2%.)
a) Range refers to the results in the various participating hospitals.
b) One centre had a far higher % of positive reactions (12%) than all others: this is a 
dermatitis patients, especially hairdressers.
referral centre with many occupational
the European standard series (formaldehyde, MCI/ and 85 to 0.05%. Of the allergic patients who were 
MI (Kathon® CG), parabens, quaternium-15). For also tested with the commercial preparation Eux-
patients reacting to 1 or more preparations of yi K 400 0.5% pet. (Chemotechnique), 69% re-
methyldibromoglutaronitrile, the following data acted to it. For the commercial allergen methyldi-
were recorded: sex, age, localization of dermatitis, bromoglutaronitrile (Trolab) 0.1% pet., the % of
patch test data, relevance of the positive reaction positive reactions was 73. No irritant reactions 
and causative product(s). were observed to any concentration of methyldi­
bromoglutaronitrile.
The scores of positive reactions to other preserv­
atives in the European standard series were 3.2% 
The results of patch testing are summarized in for MCI/MI (Kathon CG), 2.0% for formalde-
Results
Table 1. A total of 2943 patients were patch tested: hyde, 1.3% for quaternium-15 and 1.0% for param
1955 (66%) women and 988 (34%) men. Their ages 
ranged from 8-86 years, with an average of 38
years.
119 patients (4.0%) h; 
or more concentrations 
ronitrile: the % of oosith
1 Discussion
methyldibromogl Euxyl® K 400 (Schulke & Mayr, Hamburg, Ger­
many) is a relatively new preservative, used in cos­
metics for some 10 years. It contains 2 active in­
gredients: 80%> phenoxyethanol and 20%
4.1%, in men 3.8%. Of the 119 positive reactions,
84 (71%) were considered to be relevant. In 60 pa­
tients, cosmetics were the cause of the dermatitis; bromoglutaronitrile (1,2-dibromo-2,4-dicyanobu- 
in 30 cases, moistened toilet tissue was traced as lane). After the 1st report of contact dermatitis in 
the source of the allergen (in 6, both cosmetics and 1989 (3), several studies have documented cases of
ilet paper were implicated).
Of the 119 patients allergic to methyldibr
contact allergy, especially in Italy (4 6), Germany 
(7, 8) and The Netherlands (1, 9). Hausen (10) pro-
glutaronitrile, /), 103 to 0.1%) vided a review of the literature up to 1992. The aller-
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gen in Euxyl® K 400 is virtually always methyldi- 0.5% methyldibromoglutaronitrile, does not induce 
bromoglutaronitrile. The causative products are irritant reactions or sensitization. Therefore, the 
cosmetics and, notably in the Netherlands, moisten- optimal test concentration may be 0.3-0.5%.
ed toilet tissues (1,9). Addition of a rarely sensitizing emulsifier, such as
In this 1994 study, we found a prevalence of soy lecithin, is advisable for facilitating homogene-
contact allergy to methyldibromoglutaronitrile of ous dispersion. Possibly, as sorbitan sesquioleate
4% in a multicentre investigation of 2943 patients does for the fragrance mix (12), such an addition
suspected of halving contact dermatitis. Women may enhance the sensitivity of the test system. 
(4.1%) and men (3.8%) were equally affected, the 
allergenic products being mainly cosmetics in
women and moistened toilet tissues in men.
In 4 years, the prevalence of allergy to methyl- 
dibromoglutaronitrile in the Netherlands has in­
creased from 0.5%) to 4.0%. There are 2 import­
ant determining factors. 4 years ago, we tested 
methyldibromoglutaronitrile at 0.05% pet. Our 
present results clearly show that this % is too low: 
only 85 of 119 allergic patients (71%) reacted to 
it. Thus, the actual prevalence in 1991 may have 
been underestimated. Secondly, the market pene­
tration of Euxyl® K 400 has rapidly increased. In 
1990,13%) of cosmetic products sold in the 
Netherlands contained the preservative (1). Cur­
rently, an estimated 25-35% of cosmetic products 
are preserved with Euxyl® K 400, among which 
are some of the best selling brands in the main 
product categories. In addition, in 1994, methyl­
dibromoglutaronitrile was found to be present in 
15 of 24 (63%) brands and types of moist toilet 
paper (11).
From this study, we conclude that methyldibro­
moglutaronitrile is an important contact allergen 
in the Netherlands, from its presence in cosmetics 
and moistened toilet tissues. Its current rate of 
sensitization exceeds that of all preservatives in the 
European standard series, including (in 9 o f the 11 
hospitals ) methyl (chloro) isothiazolinone (Ka- 
thon® CG). Therefore, it should be added to cos­
metics series and to protological series. In coun­
tries where, as in the Netherlands, contact allergy 
to methyldibromoglutaronitrile is frequent, the 
allergen should be added to the European standard 
series.
The 2nd conclusion concerns the test concen-
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th
of 0.1% and
for
gens methyldibromoglutaronitrile 0.1%) and Eux­
yl® K 400 0.5% (containing 0.1% methyldibromog­
lutaronitrile), is likely to result in false-negatives. 
The data provided by Tosti et al. (6) suggest that
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